BRAIDWELL LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001920938

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2025 · 70 positions · Total reported value $3.18B · Top-10 concentration 46.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.0% · 24 new · 32 cut · 25 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.0% · vs SPY +9.2% · Prev Value $2.64B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, BRAIDWELL LP disclosed 70 equity positions with a combined reported value of $3.18B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 46.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were GH ($286.28M), CAI ($221.31M), NVCR ($210.04M). By sector, the heaviest allocations are Health Care 81.5%, Technology 4.1%. Versus the prior quarter, allocation shifted toward Other (+2.3pp), Consumer Staples (+1.0pp) and away from Industrials (-0.9pp), Health Care (-3.0pp).

Versus the prior quarter, BRAIDWELL LP opened 24 new positions, trimmed 32 and fully exited 25, a turnover rate of 75.0% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2025 were SLNO ($86.66M), ACAD ($50.76M), HNGE ($44.69M).

Of the 25 positions fully exited versus the prior quarter, the largest were APLS ($19.41M), MDGL ($18.39M), UNH ($15.41M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • SLNO SOLENO THERAPEUTICS INC · $86.66M
  • ACAD ACADIA PHARMACEUTICALS INC · $50.76M
  • HNGE HINGE HEALTH INC · $44.69M
  • CVS CVS HEALTH CORP · $33.07M
  • DNTH DIANTHUS THERAPEUTICS INC COM · $32.86M
  • CDNA CAREDX INC · $31.74M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $28.60M
  • THC TENET HEALTHCARE CORP · $24.71M

Fully Exited (vs previous quarter)

  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $19.41M
  • MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $18.39M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $15.41M
  • CELC CELCUITY INC · prev qtr: $11.81M
  • CBIO CRESCENT BIOPHARMA INC. · prev qtr: $4.22M

Insider Transactions (Form 4)

Latest BRAIDWELL LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Braidwell LP, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 83 positions worth $2.54B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-122966 (status: Approved), registered 2022-01-03
  • Regulatory AUM (Form ADV): $3.63B as of 2026-09-22
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 12 private funds, of which 11 hedge funds
  • Website: braidwell.com

Portfolio Structure

  • 83 positions · $2.54B reported value (Q2 2026)
  • Top 10 holdings = 32.8% of reported value
  • Largest position: CAI (CARIS LIFE SCIENCES INC) at 5.8%
  • Average position size: $30.62M

Sector Tilt

  • Health Care 90.1%
  • Information Technology 4.3%
  • Industrials 4.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 24 new, 21 added, 32 reduced, 25 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 81.5%
Technology 4.1%
Other 9.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 219.45M $286.28M 9.02%
9.02%
Add
2 7.32M $221.31M 6.97%
6.97%
Hold
3 211.36M $210.04M 6.61%
6.61%
Add
4 3.61M $144.74M 4.56%
4.56%
Hold
5 3.28M $132.25M 4.17%
4.17%
Hold
6 880.28K $123.57M 3.89%
3.89%
Reduce
7 520.40K $91.87M 2.89%
2.89%
Reduce
8 1.01M $87.60M 2.76%
2.76%
Reduce
9 1.28M $86.66M 2.73%
2.73%
New
10 62.00M $85.37M 2.69%
2.69%
Reduce
11 5.21M $84.52M 2.66%
2.66%
Hold
12 82.14M $72.90M 2.30%
2.30%
Reduce
13 883.75K $65.57M 2.06%
2.06%
Add
14 780.16K $63.62M 2.00%
2.00%
Add
15 309.34K $61.33M 1.93%
1.93%
Hold
16 1.83M $59.55M 1.88%
1.88%
Reduce
17 130.23K $58.24M 1.83%
1.83%
Add
18 1.44M $57.16M 1.80%
1.80%
Reduce
19 76.09K $56.12M 1.77%
1.77%
Reduce
20 113.93K $55.26M 1.74%
1.74%
Reduce
21 409.69K $51.30M 1.62%
1.62%
Reduce
22 2.38M $50.76M 1.60%
1.60%
New
23 910.48K $44.69M 1.41%
1.41%
New
24 2.58M $43.21M 1.36%
1.36%
Hold
25 351.25K $39.41M 1.24%
1.24%
Add
26 225.84K $38.84M 1.22%
1.22%
Reduce
27 141.53K $35.85M 1.13%
1.13%
Add
28 48.48M $34.96M 1.10%
1.10%
Hold
29 2.73M $34.54M 1.09%
1.09%
Reduce
30 438.60K $33.07M 1.04%
1.04%
New
31 835.06K $32.86M 1.03%
1.03%
New
32 2.18M $31.74M 1.00%
1.00%
New
33 528.00K $28.60M 0.90%
0.90%
New
34 498.00K $28.52M 0.90%
0.90%
Add
35 1.38M $26.58M 0.84%
0.84%
Reduce
36 195.66K $26.15M 0.82%
0.82%
Add
37 643.18K $24.97M 0.79%
0.79%
Reduce
38 121.70K $24.71M 0.78%
0.78%
New
39 8.35M $23.97M 0.76%
0.76%
Hold
40 414.60K $22.68M 0.71%
0.71%
New
41 475.40K $22.57M 0.71%
0.71%
New
42 1.51M $22.02M 0.69%
0.69%
Reduce
43 1.11M $20.53M 0.65%
0.65%
Hold
44 759.46K $19.96M 0.63%
0.63%
Reduce
45 822.74K $18.73M 0.59%
0.59%
Hold
46 303.69K $18.42M 0.58%
0.58%
New
47 588.70K $17.71M 0.56%
0.56%
New
48 342.39K $16.50M 0.52%
0.52%
Reduce
49 832.10K $16.03M 0.51%
0.51%
New
50 276.69K $15.66M 0.49%
0.49%
New

FAQ

What did BRAIDWELL LP buy in 2025-Q3?

In its 2025-Q3 13F filing, BRAIDWELL LP reported 70 equity positions worth $3.18B in aggregate; its largest disclosed positions were GH ($286.28M), CAI ($221.31M), NVCR ($210.04M).

How large is BRAIDWELL LP's portfolio?

BRAIDWELL LP reported $3.18B of long equity holdings across 70 positions as of 2025-Q3. Top-10 holdings account for 46.3% of reported value.

What is BRAIDWELL LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/braidwell/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →